Trigger the CBC: Join the Broadcasters Circle today
Researchers say AstraZeneca vaccine linked to Guillain-Barre syndrome

Thomas Lambert

May 30, 2022

Researchers at the University College London have confirmed a rise in cases of Guillain-Barre syndrome, a potentially fatal neurological disorder, following inoculation with the AstraZeneca vaccine.

Researchers say they have found a rise in cases of Guillain-Barre syndrome within two to four weeks after receiving the AstraZeneca vaccine but have not found a similar surge following inoculation with the Pfizer and Moderna vaccines.

They add that, while this is still speculation, the link may result from how the AstraZeneca vaccine delivers COVID spike proteins to the body (i.e., through a weakened chimp adenovirus referred to as a Trojan horse delivery system).

“At the moment, we don’t know why a vaccine may cause these very small rises in GBS,” says Prof Michael Lunn.

“It may be that a non-specific immune activation in susceptible individuals occurs, but if that were the case, similar risks might apply to all vaccine types. It is, therefore, logical to suggest that the simian adenovirus vector, often used to develop vaccines, including AstraZeneca’s, may account for the increased risk.”

According to the Mayo Clinic, Guillain-Barre syndrome is a rare neurological disorder that causes the body’s immune system to attack nerves. This initially leads to weakness and tingling in the extremities but quickly progresses throughout the body, often resulting in paralysis and the inability to walk, speak, or eat. While most recover, the disorder has a fatality rate of 4 to 7 per cent. Moreover, many patients experience lingering effects, including weakness, numbness, and fatigue.

There is no cure for GBS.

As reported by The Telegraph, following a single dose of AstraZeneca, researchers found an excess of 5.8 cases per million doses, leading to an excess of 98-140 cases of GBS between January-July 2021 in the UK.

Other researchers have also found that other vaccines, such as the Johnson & Johnson vaccine, similarly lead to a heightened risk of developing GBS.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

A new study indicates that the rate of re-infection of COVID is higher for those who are considered fully vaccinated.

Mike Campbell

August 15, 2022

Trending News

Pfizer CEO Albert Bourla unironically tweeted that, despite catching COVID, he was grateful for getting jabbed four times and still requiring another one of his products to treat the infection.

Mike Campbell

August 15, 2022

Trending News

Germany’s health minister, Karl Lauterbach, has unveiled a new COVID tracking app that uses colours based on health status to determine what rights someone has, just like the app used in China.

Keean Bexte

August 10, 2022

Trending News

A study published in July found that 42.1% of women who got a COVID vaccine reported heavier than usual menstrual bleeding following the jab.

Thomas Lambert

August 10, 2022

Trending News

Denmark has announced that people under the age of 18 are no longer allowed to get the COVID vaccine.

Mike Campbell

August 9, 2022

Trending News

UCP leadership candidate Danielle Smith says she wants to protect kids from the horrible impacts of lockdowns, calling them a “terrible mistake” that “can’t happen again.”

Thomas Lambert

August 8, 2022

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.